retatrutide glp-1 gip glucagon triple agonist The TRIUMPH-1 Phase 3 results just dropped on retatrutide. Here is what the numbers actually say. is a agonist. It targets GLP-1, GIP, and receptors. Ozempic targets one. Mounjaro Retatrutide Phase 3: 28.7% Weight

Mood Shifts & Emotional Eating Patients often describe this as food noise coming back overnight. Why a Supervised Taper Matters A structured GLP-1 maintenance plan (with micro-dosing) helps reduce these effects significantly

The platform states it is not itself a healthcare provider

GLP-1 patches are a wellness supplement and are not a substitute for any prescribed medication, including those for diabetes or other conditions

Serious side effects, warnings, and precautions Wegovy may also cause serious side effects, including inflammation of the pancreas (pancreatitis) and gallbladder problems

The data comes from an open, anonymous platform, where researchers cant verify who is posting or whether users are accurately reporting medication use or symptoms, says Dr